Latest News

Experimental antibody shows early promise for treatment of childhood tumor

Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody. Four patients are still alive after more than two-and-a-half years and without additional treatment. Neuroblastoma is a cancer of the sympathetic nervous system. It is the most common cancer diagnosed in the first year of life and accounts for 7 to 10 percent of childhood cancers.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Massive study reports challenges in reproducing published psychology findings

  • Four-day school week can improve academic performance, study finds

  • Cannabis and the brain

  • Awareness of memory loss may decline two-three years before dementia onset

  • 'Brainbow' reveals surprising data about visual connections in brain

  • To get girls more interested in computer science, make classrooms less 'geeky'

  • About 10 percent of mothers experienced depression two years after Hurricane Katrina

  • Alzheimer?s disease thought to be accelerated by an abnormal build-up of fat in the brain

  • Parkinson?s disease brain cells at risk of burnout, like an overheating motor

  • Creative and neurotic: Is neuroticism fueled by overthinking?

  •